[Effects of Chinese compound prescription on bone metabolism of weightlessness rats simulated by suspension]. 2008

Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
Beijing University of Traditional Chinese Medicine, Beijing 100029, China.

OBJECTIVE To study the effects of Chinese medicine compound on bone metabolism of weightlessness rats simulated by tail suspension. METHODS Fifty Wistar rats were divided into 5 groups randomly: control group, model group, and low does, medium dose and high does treated group. The experiment period lasted 21 days. After the Chinese compound prescription and distilled water were orally given to treated groups, and control and model group for 7 days, respectively, the tail suspension experiment was performed for treated and model group, meanwhile administration of Chinese compound prescription and distilled water still lasted until the end of the experiment. Blood serum was collected for determination of alkaline phosphatase (ALP), bone gla protein (BGP), tartrate-resistant acid phosphatase (TRAP), femoral bone HOP. The changes of bone mineral density (BMD) of femoral bone and lumbar vertebra were observe. RESULTS Compared with control group, the ALP level of model group was markedly decreased (P < 0.05), no change of BGP, TRAP was not observed, the BMD of femoral bone and lumbar vertebra were decreased remarkably (P < 0.05), Compared with model group, the change of ALP level of treated groups was not significant for all treated groups, the BGP level and BMD for medium dose group were increased (P < 0.05), the TRAP level for medium dose and high does groups was decreased (P < 0.05) CONCLUSIONS The Chinese compound prescription can improve the bone formation and prevent bone loss via inhibiting bone absorption and improving ossify, bone mineral deposition and mineralization as well as increasing BMD, which leads to prevention and treatment of bone loss.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D008297 Male Males
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D000071681 Tartrate-Resistant Acid Phosphatase One of several acid phosphatases in humans, other mammals, plants, and a few prokaryotes. The protein fold of tartrate-resistant acid phosphatase (TRAP) resembles that of the catalytic domain of plant purple acid phosphatase and other serine/threonine-protein phosphatases that also contain a metallophosphoesterase domain. One gene produces the various forms which include purple acid phosphatases from spleen and other tissues. Tartrate-resistant acid phosphatase is a biomarker for pathological states in which it is over-expressed. Such conditions include GAUCHER DISEASE; HODGKIN DISEASE; BONE RESORPTION; and NEOPLASM METASTASIS. AcPase V,Acid Phosphatase V,TRAP Type 5 AcPase,TRAcP,Tartrate-Resistant Acid Phosphatase Type 5,Type 5 Acid Phosphatase,Uteroferrin,Acid Phosphatase, Tartrate-Resistant,Phosphatase V, Acid,Phosphatase, Tartrate-Resistant Acid,Tartrate Resistant Acid Phosphatase,Tartrate Resistant Acid Phosphatase Type 5,V, AcPase,V, Acid Phosphatase
D000135 Acid Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.2. Acid beta-Glycerophosphatase,Acid beta Glycerophosphatase
D000469 Alkaline Phosphatase An enzyme that catalyzes the conversion of an orthophosphoric monoester and water to an alcohol and orthophosphate. EC 3.1.3.1.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015519 Bone Density The amount of mineral per square centimeter of BONE. This is the definition used in clinical practice. Actual bone density would be expressed in grams per milliliter. It is most frequently measured by X-RAY ABSORPTIOMETRY or TOMOGRAPHY, X RAY COMPUTED. Bone density is an important predictor for OSTEOPOROSIS. Bone Mineral Content,Bone Mineral Density,Bone Densities,Bone Mineral Contents,Bone Mineral Densities,Density, Bone,Density, Bone Mineral

Related Publications

Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
April 2003, Hang tian yi xue yu yi xue gong cheng = Space medicine & medical engineering,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
June 1984, Endocrinology,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
July 2002, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
April 2003, Hang tian yi xue yu yi xue gong cheng = Space medicine & medical engineering,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
January 1990, Journal of biomechanics,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
August 2003, Hang tian yi xue yu yi xue gong cheng = Space medicine & medical engineering,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
February 2007, Nan fang yi ke da xue xue bao = Journal of Southern Medical University,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
March 2013, Asian Pacific journal of tropical medicine,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
February 1987, Endocrinology,
Hai-Ying Tong, and Su-Min Hu, and Peng Zhou, and Qian Fu, and Jia Yang, and Xue-Min Gao, and Jian-Jun Zhang, and Gan-Sheng Zhong
July 2000, Indian journal of physiology and pharmacology,
Copied contents to your clipboard!